Genetic variation of the intestinal fatty acid-binding protein 2 gene in carotid atherosclerosis

Vascular Medicine

Volumn 10, Issue 2, 2005, Pages 103-108

  Wanby, Pär ^a   Palmquist, Petter ^a   Brudin, Lars ^a   Carlsson, Martin ^a  

^a KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

Carotid atherosclerosis; FABP2; Genetics; Polymorphism

Indexed keywords

FATTY ACID BINDING PROTEIN;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; STROKE; SWEDEN; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ALLELES; CAROTID ARTERY DISEASES; CARRIER PROTEINS; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; ELECTROCARDIOGRAPHY; FATTY ACID-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER; VARIATION (GENETICS);

EID: 21244458445     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x05vm609oa     Document Type: Article

References (29)

1. Rothwell PM, Eliasziw M, Gutnikov SA et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-16.
2. Zhang F, Lücke C, Baier LJ, Sacchettini JC, Hamilton JA. Solution structure of human intestinal fatty acid binding protein: Implications for ligand entry and exit. J Biomol NMR 1997; 9: 213-28.
3. Cohn SM, Simon TC, Roth KA, Birkenmeier EH, Gordon JI. Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axis of the gut epithelium. J Cell Biol 1992; 119: 27-44.
4. Baier LJ, Sacchettini JC, Knowler WC et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995; 95: 1281-87.
5. Baier LJ, Borgardus C, Sacchettini JC. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996; 271: 10892-96.
6. Carlsson M, Orho-Melander M, Hedenbro J, Almgren P, Groop LC. The T 54 allele of the fatty acid-binding protein 2 is associated with a parental history of stroke. J Clin Endocrinol Metab 2000; 85: 2801-804.
7. Hegele RA. A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components. Clin Biochem 1998; 31: 609-12.
8. Hegele RA, Harris SB, Hanley AJG, Sadikian S, Connelly PW, Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 1996; 81: 4334-37.
9. Prately RE, Baier L, Pan DA et al. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 2000; 41: 2002-08.
10. Ågren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 1998; 18: 1606-10.
11. Vidgren HM, Sipiläinen RH, Heikkinen S, Laakso M, Uusitupa MIJ. Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Eur J Clin Invest 1997; 27: 405-408.
12. Tahvanainen E, Molin M, Vainio S et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 2000; 152: 317-25.
13. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen R. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrion Examination Survey. Circulation 2004; 109: 42-46.
14. Horibe H, Yamanda Y, Ichihara S et al. Genetic risk for restenosis after coronary balloon angioplasty. Atherosclerosis 2004; 174: 181-87.
15. Hyson D, Rutledge JC, Berglund L. Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep 2003; 5: 437-44.
16. Simons LA, Dwyer T, Simons J et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 1987; 65: 181-89.
17. Groot PH, van Stiphout WA, Krauss XH et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991; 11: 653-62.
18. Sharrett AR, Chambless LE, Heiss G, Paton CC, Patsch W. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. Arterioscler Thromb Vasc Biol 1995; 15: 2122-29.
19. Ryu JE, Howard G, Craven TE, Bond G, Hagaman AP, Crouse III JR. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992; 23: 823-28.
20. Boquist S, Ruotolo G, Tang R et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 1999; 100: 723-28.
21. Karpe F, de Faire U, Mercuri M, Hellenius M-L, Hamsten A. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. Atherosclerosis 1998; 141: 307-14.
22. Jeppsson O, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobin A1c by a new liquid-chromatography assay; methodology, clinical utility, and relation to tolerance evaluated. Clin Chem 1986; 32: 1867-72.
23. Eckerbom S, Bergqvist Y. Simplified analysis for glycated hemoglobin by ion-exchange chromatography. Clin Chem 1989; 35: 2253.
24. Bluth EI, Wetzner SM, Stavros AT, Aufrichtig D, Marish KW, Baker JD. Carotid duplex sonography: A multicenter recommendation for standardized imaging and Doppler criteria. RadioGraphics 1988; 8: 487-506 (Figure 22).
25. Khaw KT. Epidemiology of stroke. J Neurol Neurosurg Psychiatry 1996; 61: 333-38.
26. Ritto D, Cramb R, Odogwu S et al. Worsening lipid profile is associated with progression of carotid artery stenosis. Int Angiol 2000; 20: 47-50.
27. Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promotor polymorphisms are associated with carotid artery stenosis. Stroke 2002; 33: 2408-12.
28. Willeit J, Kiechl S, Mair A, Santer P, Wiedermann CJ, Roemisch J. Marburg I polymorphism of factor VII-activating protease: prominent risk predictor of carotid stenosis. Circulation 2003; 107: 667-70.
29. Hunt K, Duggirala R, Göring H, Williams J, Almasy L, Blangero J. Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study. Stroke 2002; 33: 2775-80.